Metformin Use and the Outcome of Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib

BACKGROUND: The anticancer properties of metformin have been suggested in numerous experimental studies and several retrospective clinical studies show that its use is associated with improved outcome of patients with cancer. However, limited data are available for patients with metastatic renal cel...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Manag Res
Main Authors: Fiala, Ondřej, Ostašov, Pavel, Rozsypalová, Aneta, Hora, Milan, Šorejs, Ondřej, Šustr, Jan, Bendová, Barbora, Trávníček, Ivan, Filipovský, Jan, Fínek, Jindřich, Büchler, Tomáš
Formato: Artigo
Idioma:Inglês
Publicado: Dove 2021
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8153069/
https://ncbi.nlm.nih.gov/pubmed/34054309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S305321
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares